arginine has been researched along with prolyl-phenylalanyl-arginine-4-nitroanilide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colman, RW; Scott, CF; Tschesche, HR; Wenzel, HR | 1 |
| Kumar, A; Mikolajczyk, SD; Millar, LS; Saedi, MS | 1 |
2 other study(ies) available for arginine and prolyl-phenylalanyl-arginine-4-nitroanilide
| Article | Year |
|---|---|
Kinetics of inhibition of human plasma kallikrein by a site-specific modified inhibitor Arg15-aprotinin: evaluation using a microplate system and comparison with other proteases.
Topics: Aprotinin; Arginine; Clinical Enzyme Tests; Evaluation Studies as Topic; Factor XI; Factor XIa; Factor XII; Factor XIIa; Fibrinolysin; Humans; Kallikreins; Kinetics; Microchemistry; Oligopeptides; Peptide Fragments; Peptide Hydrolases; Structure-Activity Relationship; Thrombin | 1987 |
Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors.
Topics: alpha 1-Antichymotrypsin; alpha 1-Antitrypsin; alpha-2-Antiplasmin; Amino Acid Sequence; Animals; Antithrombin III; Arginine; Biomarkers, Tumor; Cell Line; Chromogenic Compounds; Cricetinae; Humans; Kallikreins; Male; Molecular Sequence Data; Oligopeptides; Peptides; Prostatic Neoplasms; Recombinant Fusion Proteins; Serine Proteinase Inhibitors; Serpins; Substrate Specificity; Tissue Kallikreins | 1998 |